Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Open-label, Randomized, Controlled Non-inferiority Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter Versus Traditional PIV in the Chinese Population

NCT04719377 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT04719377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04719377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Open-label, Randomized, Controlled Non-inferiority Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter Versus Traditional PIV in the Chinese Population
Lead sponsor
Becton, Dickinson and Company
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2021
Completion date
January 30, 2022
Enrollment
256 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

catheterization